Vertex Pharmaceuticals (VRTX) Cash from Investing Activities (QoQ) (2009 - 2026)
Vertex Pharmaceuticals (VRTX) Cash from Investing Activities (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.55 Bn | 54.80 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.91% |
| Dec 31, 2025 | -146.24% |
| Sep 30, 2025 | 75.85% |
| Jun 30, 2025 | -768.28% |
| Mar 31, 2025 | 93.21% |
| Dec 31, 2024 | -136.18% |
| Sep 30, 2024 | 24.95% |
| Jun 30, 2024 | 78.30% |
| Mar 31, 2024 | -140.99% |
| Dec 31, 2023 | -653.19% |
| Sep 30, 2023 | 61.27% |
| Jun 30, 2023 | 83.43% |
| Mar 31, 2023 | -1,144.19% |
| Dec 31, 2022 | 145.71% |
| Sep 30, 2022 | -524.72% |
| Jun 30, 2022 | -20.59% |
| Mar 31, 2022 | 61.94% |
| Dec 31, 2021 | -153.31% |
| Sep 30, 2021 | 33.63% |
| Jun 30, 2021 | -7.27% |